Similarly, the analysis of pairwise joint associations of TP53 Arg72Pro and XPD Lys751Gln genotypes with lung cancer risk showed the statistically non-significant result, although the odds ratios of combined mutant or deficient variants of the studied genes were higher in lung cancer patients than controls. The gene discussed is TP53; the disease is lung carcinoma.